Lawrence Scott Blaszkowsky MD

Instructor in Medicine, Massachusetts General Hospital

2014 Washington StreetHematology/OncologyNewton, MA 02462
Phone+1 617-219-1230
Fax+1 617-831-7350

Dr. Blaszkowsky is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blaszkowsky's full profile Already have an account?

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1990 - 1993
SUNY Upstate Medical UniversityClass of 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1995 - 2028
NY State Medical License 1991 - 1996
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017

Clinical Trials

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
TERMINATED
PHASE1, PHASE2
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
COMPLETED
PHASE1, PHASE2
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
COMPLETED
PHASE2

Publications & Presentations

PubMed

Therapeutic Targeting of Epithelial-Mesenchymal Cellular Plasticity in Pancreatic Cancer.
Eric W Lin, Priyadarshini Pathak, Aileen O'Shea, Beatrice Awasthi, Ildiko E Phillips
Clinical Cancer Research. 2026-03-02
1 citations
To contrast or not to contrast? Evaluating the diagnostic accuracy of hepatobiliary contrast agents in liver FDG-PET/MR: a prospective study.
Luigi Asmundo, Felipe Furtado, Francis Delaney, Mojtahed Amirkasra, Azadeh Hajati
European Journal of Nuclear Medicine and Molecular Imaging. 2025-10-01
1 citations
Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials.
Grace Lee, Bailey Nelson, Julie Koenig, John P Plastaras, James M Metz
International Journal of Radiation Oncology, Biology, Physics. 2025-05-01

Press Mentions

Folfox+Irinotecan+Chemort in Esophageal CancerDecember 7th, 2020
Losartan and Nivolumab in Combination with FOLFIRINOX and SBRT in Localized Pancreatic CancerJune 20th, 2018
Newton-Wellesley Hospital Expands Partnership with Mass General Cancer CenterMarch 15th, 2018